Tag: brian hill

T-cells_650x450
December 9, 2019/Research

Findings Suggest CAR T-Cell Therapy is Highly Effective for Relapsed/Refractory Mantle Cell Lymphoma

Autologous anti-CD19 agent produces impressive survival improvements

nci-vol-2335-72_650x450
July 20, 2018/Research

Brian Hill, MD, PhD, and Mikkael Sekeres, MD, MS, Chair State of the Science Summit

OncLive summit on hematologic malignancies Oct. 4

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

CAR-T cell_650x450
June 26, 2018/Blood Cancers

Cancer Center Offers Chimeric Antigen Receptor T-Cell Therapy

Cleveland Clinic's approach to the therapy

Dr.-Hill_650x450
December 11, 2017/Research

Long-Term Follow-Up of ZUMA-1 Shows Significant Clinical Benefit (Video)

Anti-CD19 CAR T cell therapy an option for patients with no others

Dr.-Hill_650x450
December 10, 2017/Research

Autologous Hematopoietic Cell Transplant Improves Survival in Mantle Cell Lymphoma

Multicenter study shows survival benefit for patients ≤ 65

newdrug_690x380 cancer
April 9, 2015/News & Insight

FDA OKs Zarxio as First Biosimilar Drug

Approval may spur competition, cost savings

DrHill_690x380
December 5, 2014/Research

Research Sheds Light on Ethnic Discrepancies in CLL

Novel, large-scale study links ethnicity-specific genes to chronic lymphocytic leukemia

BackPage 1 of 1Next
Advertisement
Ad